02197.HK
Clover Biopharmaceuticals, Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 2.10
+3.96%Margins
Gross margin
-1337.1%
EBITDA margin
-2159.3%
EBIT margin
-2266.0%
Net margin
-127.0%
FCF margin
-624.9%
8.3%
Return on equity
-27.4%
Return on assets
148.0%
Return on invested capital
0.15x
Asset turnover
-HKD 380.2M
Cash from operations
HKD 0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026